Roche And Prothena Will Advance Prasinezumab Into Late-Stage Clinical Development Study In Parkinson’s Disease Read more
Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model Read more
Immune Therapeutics Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs Read more
Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva to treat dialysis patients with pruritus Read more
Tagrisso granted Priority Review in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer Read more
Xeris Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection Read more
NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4 Read more
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment Read more